Related Experiment Video
Updated: Jun 27, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Cervical cancer screening in the early post vaccine era
1Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, University of New Mexico, MSC10 5580, Albuquerque, NM 87131-0001, USA. awaxman@salud.unm.edu
Abstract:
The Pap test is the foundation of cervical cancer screening in North America and most industrialized countries. It has been widely used in the United States since the 1950s. But are our current screening guidelines still justified? In this article, the author reviews the current recommendations for cervical cancer screening by the American Cancer Society (ACS) and the American College of Obstetricians and Gynecologists (ACOG) and the evidence supporting them, reviews the relative efficacy of liquid-based cytology versus the conventional Pap smear, and discusses the role of HPV DNA testing in primary screening.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Smallpox
Vaccinations
Vaccines
Preventive Healthcare Services
Cancer Prevention
Some...